View in EDS

633P Tolerability and treatment response to darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in the phase III ARAMIS trial.

Saved in:
Bibliographic Details
Title: 633P Tolerability and treatment response to darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in the phase III ARAMIS trial.
Authors: Fizazi, K.1 (AUTHOR), Shore, N.2 (AUTHOR), Smith, M.R.3 (AUTHOR), Tammela, T.L.4 (AUTHOR), Le Berre, M-A.5 (AUTHOR), Petrenciuc, O.6 (AUTHOR), Zurth, C.7 (AUTHOR), Kuss, I.7 (AUTHOR)
Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS522-S522. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152695427
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 633P Tolerability and treatment response to darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in the phase III ARAMIS trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Fizazi%2C+K%2E%22">Fizazi, K.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shore%2C+N%2E%22">Shore, N.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Smith%2C+M%2ER%2E%22">Smith, M.R.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tammela%2C+T%2EL%2E%22">Tammela, T.L.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Le+Berre%2C+M-A%2E%22">Le Berre, M-A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Petrenciuc%2C+O%2E%22">Petrenciuc, O.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zurth%2C+C%2E%22">Zurth, C.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kuss%2C+I%2E%22">Kuss, I.</searchLink><relatesTo>7</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS522-S522. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152695427
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2020.08.892
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S522
    Titles:
      – TitleFull: 633P Tolerability and treatment response to darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in the phase III ARAMIS trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fizazi, K.
      – PersonEntity:
          Name:
            NameFull: Shore, N.
      – PersonEntity:
          Name:
            NameFull: Smith, M.R.
      – PersonEntity:
          Name:
            NameFull: Tammela, T.L.
      – PersonEntity:
          Name:
            NameFull: Le Berre, M-A.
      – PersonEntity:
          Name:
            NameFull: Petrenciuc, O.
      – PersonEntity:
          Name:
            NameFull: Zurth, C.
      – PersonEntity:
          Name:
            NameFull: Kuss, I.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2020 Supplement 4
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 31
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1